Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhaoyi Liu

Showing results (61-70 of 69) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 69 results.
JCO Precision Oncology|March 23, 2023
Efficacy of Immune Checkpoint Inhibitor Plus Chemotherapy in Patients With <i>ROS1</i>-Rearranged Advanced Lung Adenocarcinoma: A Multicenter, Retrospective Cohort StudyZhe Huang, Huan Yan, Liang Zeng, et al.
Journal of Environmental Management|March 21, 2026
Poly(deep eutectic solvent)@MOF-801 for technical surveillance of carbaryl: Pesticide residue safety control strategyXicheng He, Yumin Yang, Ying Cao, et al.
Iscience|October 1, 2024
Development of a prognostic nomogram for advanced non-small cell lung cancer using clinical characteristicsHaoyue Qin, Zhe Huang, Huan Yan, et al.
Med (New York, N.Y.)|March 23, 2024
First-in-human phase I study of BEBT-109 in previously treated EGFR exon 20 insertion-mutated advanced non-small cell lung cancerLiang Zeng, Lianxi Song, Li Liu, et al.
Blood|March 25, 2025
Tracking clusterin expression in hematopoietic stem cells reveals their heterogeneous composition across the lifespanShuhei Koide, Motohiko Oshima, Takahiro Kamiya, et al.
Iscience|August 20, 2025
Lymphocyte subset-based non-invasive biomarker predicts immunochemotherapy efficacy in EGFR-TKI-pretreated EGFR-mutated NSCLCLianxi Song, Liang Zeng, Qinqin Xu, et al.
Cancer Immunology, Immunotherapy : CII|March 7, 2024
Clinical evidence for efficacy of pembrolizumab in MSI-H and TMB-H advanced solid tumor: results from three cancer centers in ChinaHuan Yan, Lianxi Song, Yizhi Li, et al.
Lung Cancer (Amsterdam, Netherlands)|May 25, 2024
Clinical treatment patterns, molecular characteristics and survival outcomes of ROS1-rearranged non-small cell lung cancer: A large multicenter retrospective studyZhe Huang, Yuda Zhang, Qinqin Xu, et al.
Frontiers in Genetics|November 15, 2021
MicroRNA Variants and HLA-miRNA Interactions are Novel Rheumatoid Arthritis Susceptibility FactorsShicheng Guo, Yehua Jin, Jieru Zhou, et al.
Pageof 7

Showing results (61-70 of 69) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 69 results.
JCO Precision Oncology|March 23, 2023
Efficacy of Immune Checkpoint Inhibitor Plus Chemotherapy in Patients With <i>ROS1</i>-Rearranged Advanced Lung Adenocarcinoma: A Multicenter, Retrospective Cohort StudyZhe Huang, Huan Yan, Liang Zeng, et al.
Journal of Environmental Management|March 21, 2026
Poly(deep eutectic solvent)@MOF-801 for technical surveillance of carbaryl: Pesticide residue safety control strategyXicheng He, Yumin Yang, Ying Cao, et al.
Iscience|October 1, 2024
Development of a prognostic nomogram for advanced non-small cell lung cancer using clinical characteristicsHaoyue Qin, Zhe Huang, Huan Yan, et al.
Med (New York, N.Y.)|March 23, 2024
First-in-human phase I study of BEBT-109 in previously treated EGFR exon 20 insertion-mutated advanced non-small cell lung cancerLiang Zeng, Lianxi Song, Li Liu, et al.
Blood|March 25, 2025
Tracking clusterin expression in hematopoietic stem cells reveals their heterogeneous composition across the lifespanShuhei Koide, Motohiko Oshima, Takahiro Kamiya, et al.
Iscience|August 20, 2025
Lymphocyte subset-based non-invasive biomarker predicts immunochemotherapy efficacy in EGFR-TKI-pretreated EGFR-mutated NSCLCLianxi Song, Liang Zeng, Qinqin Xu, et al.
Cancer Immunology, Immunotherapy : CII|March 7, 2024
Clinical evidence for efficacy of pembrolizumab in MSI-H and TMB-H advanced solid tumor: results from three cancer centers in ChinaHuan Yan, Lianxi Song, Yizhi Li, et al.
Lung Cancer (Amsterdam, Netherlands)|May 25, 2024
Clinical treatment patterns, molecular characteristics and survival outcomes of ROS1-rearranged non-small cell lung cancer: A large multicenter retrospective studyZhe Huang, Yuda Zhang, Qinqin Xu, et al.
Frontiers in Genetics|November 15, 2021
MicroRNA Variants and HLA-miRNA Interactions are Novel Rheumatoid Arthritis Susceptibility FactorsShicheng Guo, Yehua Jin, Jieru Zhou, et al.
Pageof 7